白塞综合征整体损害指数(BODI)的开发与初步验证
本研究基于120条文献条目,经国际多学科Delphi共识制定白塞综合征整体损害指数(BODI),并在228例患者的多中心横断面队列中初步验证。BODI包含4条总体原则和46个未加权条目,分属9个器官域,信度良好至优秀,与VDI显著相关(r=0.693,p<0.001),且与疾病活动度指标不相关。
要点
- BODI由4条总体原则和46个未加权条目组成,覆盖9个器官域。
- BODI信度良好至优秀:平均Cohen's k为0.84(95%CI 0.78-0.90),平均ICC为0.88(95%CI 0.80-0.95)。
- BODI与VDI显著相关(r=0.693,p<0.001),与疾病活动度指标不相关,可区分损害与活动。
核心结论
- BODI是经过共识制定并初步验证的、用于评估白塞综合征患者器官损害的指数,待进一步验证后可用于观察性和对照试验。
研究设计与样本
- 从120条文献检索的初步条目出发,经国际多学科专家组(风湿科、内科、眼科、神经科医生及患者代表)多轮Delphi共识确定最终内容。
- 在228例白塞综合征患者的多中心横断面队列中验证BODI,评估其与VDI和疾病活动度指标的相关性、内容效度、表面效度和可行性。
主要发现
- 最终BODI包含4条总体原则和46个未加权条目,分属9个器官域。
- BODI信度良好至优秀,平均Cohen's k为0.84(95%CI 0.78-0.90),平均组内相关系数为0.88(95%CI 0.80-0.95)。
- 128例(56.1%)患者BODI评分≥1,中位评分为1.0(范围0-14)。
- BODI与VDI显著相关(r=0.693,p<0.001),在识别主要器官损害方面更敏感。
- BODI与疾病活动度指标不相关(BDCAF:p=0.807;PGA:p=0.820;PtGA:p=0.794)。
关键数值与推荐
- BODI包含4条总体原则和46个未加权条目,分属9个器官域。
- BODI与VDI的相关系数r=0.693(p<0.001)。
- BODI与BDCAF、PGA、PtGA的p值分别为0.807、0.820、0.794。
临床怎么用
- BODI可用于评估白塞综合征患者的器官损害,待进一步验证后适用于观察性和对照试验。
- BODI与疾病活动度指标不相关,有助于区分损害与疾病活动。
局限性
- 结论指出BODI仍需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop and validate the evidence-based and consensus-based Behçet's Syndrome Overall Damage Index (BODI). METHODS: Starting from 120 literature-retrieved preliminary items, the BODI underwent multiple Delphi rounds with an international multidisciplinary panel consisting of rheumatologists, internists, ophthalmologists, neurologists, and patient delegates until consensus was reached on the final content. The BODI was validated in a cross-sectional multicentre cohort of 228 patients with Behçet's syndrome (BS) through the study of (a) correlation between BODI and Vasculitis Damage Index (VDI) and (b) correlation between BODI and disease activity measures (ie, Behçet's Disease Current Activity Form (BDCAF), Physician Global Assessment (PGA), Patient Global Assessment (PtGA)), c) content and face validity and (d) feasibility. RESULTS: The final BODI consists of 4 overarching principles and 46 unweighted-items grouped into 9 organ domains. It showed good to excellent reliability, with a mean Cohen's k of 0.84 (95% CI 0.78 to 0.90) and a mean intra-class correlation coefficient of 0.88 (95% CI 0.80 to 0.95). Overall, 128 (56.1%) patients had a BODI score ≥1, with a median score of 1.0 (range 0-14). The BODI significantly correlated with the VDI (r=0.693, p<0.001), demonstrating to effectively measure damage (construct validity), but had greater sensitivity in identifying major organ damage and did not correlate with disease activity measures (ie, BDCAF: p=0.807, PGA: p=0.820, PtGA: p=0.794) discriminating damage from the major confounding factor. The instrument was deemed credible (face validity), complete (content validity) and feasible by an independent group of clinicians. CONCLUSIONS: Pending further validation, the BODI may be used to assess organ damage in patients with BS in the context of observational and controlled trials.
引用
- Piga M, Floris A, Espinosa G, et al. Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI). RMD Open. 2020. PMID: 32703843. doi:10.1136/rmdopen-2020-001192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。